FAITH FRIENDLY WEB

ANTIRA
BLOG FOR GOD
GOLDEN RULE ADVOCACY
MAGNANAMAS
REMINDER VERSE®
THE LIGHT MINISTRIES
TheChristianChroniclesC100
previous arrow
next arrow

Popular

500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
500px DUAL FREE TO BE LOGO black letters
previous arrow
next arrow

Trending

OPTIONS MARKET

Brad Pitt Channel
Viola Davis Channel
Denzel Washington Channel
Jamie Lee Curtis Channel
Bradley Cooper Channel
Cate Blanchett Channel
Jason Statham Channel
Anya Chalotra Channel
Colin Farrell Channel
Meryl Streep Channel
Morgan Freeman Channel
Nicole Kidman Channel
Idris Elba Channel
Scarlett Johansson Channel
Benedict Cumberbatch Channel
Gina Carano Channel
Keanu Reeves Channel
Constance Wu Channel
Kevin Hart Channel
Amy Adams Channel
Laurence Fishburne Channel
Letitia Wright Channel
Liam Neeson Channel
Emilia Clarke Channel
Mark Ruffalo Channel
Diana Silvers Channel
Matthew McConaughey Channel
Betty Gilpin Channel
Tom Cruise Channel
Elizabeth Debicki Channel
Tom Hanks Channel
Alba Baptista Channel
Will Smith Channel
Zoe Saldana Channel
Hugh Jackman Channel
Brianna Hildebrand Channel
Gary Oldman Channel
Aya Cash Channel
Christian Bale Channel
previous arrow
next arrow
Purchase an Option on a Celebrity channel now for $X
and transfer it to the Celebrity later for $X+.

RECOMMENDED

Declaration of a Peaceful Revolution

FDA approves expanded use of AbbVie’s arthritis drug to treat eczema

(Reuters) – The U.S. Food and Drug Administration approved the expanded use of AbbVie Inc’s arthritis drug to treat eczema, a skin disease, the company said on Friday.

The approval of Rinvoq for the treatment of moderate to severe atopic dermatitis, or eczema, was for patients 12 years and older who do not respond to previous treatment or when use of other treatments is not recommended.

Approval for Rinvoq follows significant delays amid concerns over safety of the class of drugs it belongs to, called JAK inhibitors, which block inflammation-causing enzymes known as Janus kinases and target a range of autoimmune diseases.

The FDA last month added its strictest warning to labels of JAK inhibitor drugs from Pfizer, Eli Lilly and AbbVie following the agency’s review of Pfizer’s Xeljanz, in which initial results from a trial showed an increased risk of serious heart-related problems and cancer in some patients being treated with the drug.

(Reporting by Leroy Leo; Editing by Shailesh Kuber)

Source link

Releted Lessons Tutorials

SUGGESTIONS
Find Almost Anything Locally

Loading the adverslides

Please wait a while